期刊文献+

骨科肝素诱导血小板减少症的预防及护理干预 被引量:1

Prevention and nursing intervention of heparin induced throm-bocytopenia in department of orthopedics
下载PDF
导出
摘要 目的:探讨骨科肝素诱导血小板减少症的预防及护理干预措施。方法:收治骨科肝素治疗患者421例,分为两组。对照组给予常规护理,观察组在常规护理基础上给予综合护理,比较两组血小板减少的发生率、静脉血栓的发生率。结果:对照组发生肺栓塞1例。观察组血小板计数<50×109/L发生率1.02%,显著低于对照组,差异有统计学意义(P<0.05)。结论:预见性医疗护理措施可以减少肝素诱导血小板减少症的不良结局。 Objective:To explore the prevention and nursing intervention measures of heparin induced throm-bocytopenia in department of orthopedics.Methods:421 cases of patients treated with heparin in department of orthopedics were divided into two groups.The control group was given routine nursing,while the observation group was given comprehensive nursing on the basis of routine nursing.The incidence of thrombocytopenia and incidence of venous thrombosis between groups were compared.Results:There were one case of pulmonary embolism in the control group.The incidence of platelet count 50×10^9/L in the observation group was 1.02%,which was significantly lower than that of the control group,and the difference was statistically significant(P〈0.05).Conclusion:Foreseeable medical care measures could reduce the adverse outcome of heparin induced throm-bocytopenia.
作者 陈雪 彭玲玲 阳丽 向吉瑶 刘艳梅 Chen Xue;Peng Lingling;Y-ang Li;Xiang diyao;Liu Yanmei(Department of Orthopedics,the People's Hospital of Deyang City 618000)
出处 《中国社区医师》 2018年第18期159-160,共2页 Chinese Community Doctors
关键词 骨科 肝素诱导血小板减少症 血栓 预防 Department of orthopedics Heparin induced throm-bocytopenia Thrombus Prevention
  • 相关文献

参考文献6

二级参考文献63

  • 1张晓蓉,何文,唐华,梁晓宁,徐利群,戴可定,高堃.小腿静脉血栓的影像学诊断[J].中国医学影像技术,2004,20(7):1064-1067. 被引量:55
  • 2徐光,苏里亚,彭禹.小腿肌间静脉丛血栓和腓肠肌血肿的超声诊断价值[J].中国医学影像技术,2007,23(5):741-743. 被引量:30
  • 3赵彬,梅丹,李拥军,管珩.肝素诱导的血小板减少症[J].中国药师,2007,10(8):822-824. 被引量:12
  • 4王勇德,孙中华,钟明惠,齐向前.肝素诱导血小板减少症一例的循证治疗[J].中华内科杂志,2007,46(8):678-680. 被引量:3
  • 5Untch B, Ahmad S, Jeske WP, et al. Prevalence, isotype,and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role oflgG[J]. Thromb Res,
  • 6Blank M, Shoenfeld Y, Tavor S, et al. Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells[J]. Int Immunol, 2002, 14(2):121.
  • 7Kibbe MR, Rhee RY. Heparin-induced thrombocytopenia: Pathophysiology[J]. Semin Vasc Surg, 1996, 9(1):284.
  • 8Robinson JA, Lewis BE.Plasmapheresis in the management of heparin-induced thrombocytopenia [J]. Semin Hematol, 1999, 36(1 Supp1 1):29.
  • 9Kelton JG. Heparin-induced thrombocytopenia: an overview [J]. Blood Rev, 2002, 16(1):77.
  • 10Walenga JM, Jeske WP, Wood J J, et al. Laboratory tests for heparin-induced thrombocytopenia: a multicenter study [J]. Semin Hematol, 1999, 36(1 Suppl 1):22.

共引文献64

同被引文献18

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部